MOBILE HEALTH TECHNOLOGY FOR THE PREVENTION OF TYPE 2 DIABETES - mDiab

Biotechnology Industry Research Assistance Council BIRAC0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Android Smartphone users between 20 and 65 years of age
•a) BMI greater than or equal to 25 kg/m2 and/or
•b) IDRS greater than or equal to 60 and/or
•c) IDRS greater than or equal to 40 and BMI greater than or equal to 23 kg/m2 and/or
•d) BMI greater than or equal to 23 kg/m2 and random (110â??199 mg/dl) (or) fasting (100 to 125 mg/dl) capillary glucose indicating
•prediabetes and/or
•e) IDRS greater than or equal to 40 and random (110 to 199 mg/dl) (or) fasting (100â??125 mg/dl) capillary glucose indicating prediabetes

•Participants involved in other wellness programs, self reported and newly diagnosed diabetes
•Those who have underone any major surgery (especially cardiovascular or bariatric) within the part three years
•Type 1 Diabetes
•Cardiovascular disorders, Advanced stage cancer, kidney failure and or on dialysis
•Inability to walk and orthopedic disabilities

发起方

Biotechnology Industry Research Assistance Council BIRAC